Frias JP - Search Results

1

Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen.

Edelman SV, Bode BW, Bailey TS, Kipnes MS, Brunelle R, Chen X, Frias JP. Edelman SV, et al. Among authors: frias jp. Diabetes Technol Ther. 2010 Aug;12(8):627-33. doi: 10.1089/dia.2010.0034. Diabetes Technol Ther. 2010. PMID: 20615104 Clinical Trial.

2

Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.

Frias JP, Yu JG, Kruszynska YT, Olefsky JM. Frias JP, et al. Diabetes Care. 2000 Jan;23(1):64-9. doi: 10.2337/diacare.23.1.64. Diabetes Care. 2000. PMID: 10857970 Clinical Trial.

3

Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women.

Frias JP, Macaraeg GB, Ofrecio J, Yu JG, Olefsky JM, Kruszynska YT. Frias JP, et al. Diabetes. 2001 Jun;50(6):1344-50. doi: 10.2337/diabetes.50.6.1344. Diabetes. 2001. PMID: 11375335

4

Pramlintide in the treatment of diabetes.

Edelman SV, Darsow T, Frias JP. Edelman SV, et al. Among authors: frias jp. Int J Clin Pract. 2006 Dec;60(12):1647-53. doi: 10.1111/j.1742-1241.2006.01187.x. Int J Clin Pract. 2006. PMID: 17109671 Clinical Trial.

5

Pramlintide as an adjunct to insulin in patients with type 2 diabetes in a clinical practice setting reduced A1C, postprandial glucose excursions, and weight.

Karl D, Philis-Tsimikas A, Darsow T, Lorenzi G, Kellmeyer T, Lutz K, Wang Y, Frias JP. Karl D, et al. Among authors: frias jp. Diabetes Technol Ther. 2007 Apr;9(2):191-9. doi: 10.1089/dia.2006.0013. Diabetes Technol Ther. 2007. PMID: 17425446 Clinical Trial.

6

Incretins and their role in the management of diabetes.

Frias JP, Edelman SV. Frias JP, et al. Curr Opin Endocrinol Diabetes Obes. 2007 Aug;14(4):269-76. doi: 10.1097/MED.0b013e32825ea2ba. Curr Opin Endocrinol Diabetes Obes. 2007. PMID: 17940451 Review.

7

Patient-reported outcomes from a 16-week open-label, multicenter study of insulin pump therapy in patients with type 2 diabetes mellitus.

Rubin RR, Peyrot M, Chen X, Frias JP. Rubin RR, et al. Among authors: frias jp. Diabetes Technol Ther. 2010 Nov;12(11):901-6. doi: 10.1089/dia.2010.0075. Epub 2010 Sep 30. Diabetes Technol Ther. 2010. PMID: 20879963 Clinical Trial.

8

Associations between improved glucose control and patient-reported outcomes after initiation of insulin pump therapy in patients with type 2 diabetes mellitus.

Peyrot M, Rubin RR, Chen X, Frias JP. Peyrot M, et al. Among authors: frias jp. Diabetes Technol Ther. 2011 Apr;13(4):471-6. doi: 10.1089/dia.2010.0167. Epub 2011 Feb 28. Diabetes Technol Ther. 2011. PMID: 21355725 Clinical Trial.

9

A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injections.

Frias JP, Bode BW, Bailey TS, Kipnes MS, Brunelle R, Edelman SV. Frias JP, et al. J Diabetes Sci Technol. 2011 Jul 1;5(4):887-93. doi: 10.1177/193229681100500410. J Diabetes Sci Technol. 2011. PMID: 21880230 Free PMC article. Clinical Trial.

10

Pramlintide improved measures of glycemic control and body weight in patients with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion therapy.

Herrmann K, Frias JP, Edelman SV, Lutz K, Shan K, Chen S, Maggs D, Kolterman OG. Herrmann K, et al. Among authors: frias jp. Postgrad Med. 2013 May;125(3):136-44. doi: 10.3810/pgm.2013.05.2635. Postgrad Med. 2013. PMID: 23748514 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page